Hendrik Peter Scholl sold $1.3M of Belite Bio (BLTE)

Executed Jun 16, disclosed Jun 17, 1 day later.

Value, as filed

$1.3M

8,910 sh across 5 lots

Executed

Jun 16

the trade date, as filed

Disclosed

Jun 17

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

HS Hendrik Peter Scholl Chief Medical Officer profile →

Hendrik Peter Scholl (Chief Medical Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Belite Bio, Inc (BLTE). The largest single filing was $1.4M of BLTE (9,808 sh across 3 lots, as filed), executed Jun 18.

The name

BLTE Belite Bio, Inc BLTE · Healthcare · 7 filings in 24 months ticker →

Healthcare · Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Hendrik Peter Scholl in BLTE

BLTESALE Belite Bio, Inc $1.4M
9,808 sh across 3 lots
Exec Jun 18
Filed Jun 22 · 5:30 PM ET